[P3] A

[P3-004-A] Comparison of the efficacy and economic benefit of two inactivated vaccines against Mycoplasma hyopneumoniae

*Tianning Yang¹, Wentao Fei¹, Pan Tu¹, Ming Hsun Wu², Ignacio Bernal Orozco², Lorena Nodar Balseiro², Hyun Dong Noh² (1. HIPRA CHINA (China), 2. HIPRA (Spain))

Keywords:

Mycoplasma hyopneumoniae,Inactivated vaccine